-- Kepler Cheuvreux on Monday downgraded electrification and automation company ABB (ABBN.SW) to hold from buy and increased its price target to 80.00 francs from 75.00 francs.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
InSilico Medicine (HKG:3696) said its investigational new drug application for an inhaled formulation of Rentosertib has been approved by China's National Medical Products Administration, according to a Wednesday Hong Kong bourse filing.The company said the drug is intended for the treatment of idiopathic pulmonary fibrosis.The approval supports a Phase 1 clinical study to evaluate safety, tolerability, and pharmacokinetics, the filing said.
China Petroleum & Chemical (HKG:0386, SHA:600028) or Sinopec reported a 28% jump in net profit in the first quarter to 17 billion yuan from 13.3 billion yuan a year earlier, according to filings with the Hong Kong and Shanghai bourses late Tuesday.Earnings per share climbed to 0.141 yuan from 0.109 yuan.Revenue fell 3.9% to 706.7 billion yuan from 735.4 billion yuan, the oil and gas company said.
Stanmore Resources (ASX:SMR) reported saleable production of 3.2 million tonnes for the first quarter, according to a Wednesday Australian bourse filing.The company reported saleable production of 3.3 million tonnes for the same period a year ago, an earlier filing showed.Total coal sales were 3 million tonnes at an average sales price of $152 per tonne, compared with 3.2 million tonnes at $139 per tonne in the same period last year.The company maintained its saleable production guidance, with record performances in March providing a strong base for the remainder of 2026, while the Isaac Downs Extension project approvals pathway is progressing as planned, with the Environmental Impact Statement on track for submission in the second quarter.